Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merabet

Showing results (321-330 of 359) with videos related to

Pageof 36
Sort By:
Pediatric Neurology|October 30, 2025
Involvement of the Posterior Visual Pathway Correlates With Higher-Order Visual Impairment in Childhood Stroke Participants Detected by Virtual Reality/Eye-Tracking ParadigmEmily Da Cruz, Diana Tambala, Anna Lynch, et al.
British Journal of Haematology|March 20, 2024
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO)Kamel Laribi, Stéphanie Poulain, Lise Willems, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|May 4, 2012
Invasive lobular carcinoma of the breast: MRI pathological correlation following bilateral total mastectomyAude Stivalet, Alain Luciani, Frederic Pigneur, et al.
Leukemia|December 9, 2025
Late toxicity and long-term efficacy of first-line bendamustine and rituximab combination in patients with Waldenström macroglobulinemiaVéronique Leblond, Jean-Richard Eveillard, Driss Chaoui, et al.
Clinical and Translational Radiation Oncology|August 11, 2018
Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinicAnna Patrikidou, Pierre Maroun, Jean-Jacques Patard, et al.
Brain Stimulation|November 1, 2011
Clinical research with transcranial direct current stimulation (tDCS): challenges and future directionsAndre Russowsky Brunoni, Michael A Nitsche, Nadia Bolognini, et al.
Frontiers in Immunology|February 4, 2025
Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccineSylvain Lamure, Houria Hendel Chavez, Marie-Ghislaine de Goër de Herve, et al.
Journal of Medicinal Chemistry|July 26, 2019
Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of OsteoporosisAhmed S Abdelsamie, Mohamed Salah, Lorenz Siebenbürger, et al.
Digestive Diseases and Sciences|July 2, 2020
Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective StudyYasmina Ben Merabet, Coralie Barbe, Alexandra Heurgue-Berlot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2014
MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression arrayLaurence Albiges, Justine Guegan, Audrey Le Formal, et al.
Pageof 36

Showing results (321-330 of 359) with videos related to

Sort By:
Pageof 36
Pediatric Neurology|October 30, 2025
Involvement of the Posterior Visual Pathway Correlates With Higher-Order Visual Impairment in Childhood Stroke Participants Detected by Virtual Reality/Eye-Tracking ParadigmEmily Da Cruz, Diana Tambala, Anna Lynch, et al.
British Journal of Haematology|March 20, 2024
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO)Kamel Laribi, Stéphanie Poulain, Lise Willems, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|May 4, 2012
Invasive lobular carcinoma of the breast: MRI pathological correlation following bilateral total mastectomyAude Stivalet, Alain Luciani, Frederic Pigneur, et al.
Leukemia|December 9, 2025
Late toxicity and long-term efficacy of first-line bendamustine and rituximab combination in patients with Waldenström macroglobulinemiaVéronique Leblond, Jean-Richard Eveillard, Driss Chaoui, et al.
Clinical and Translational Radiation Oncology|August 11, 2018
Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinicAnna Patrikidou, Pierre Maroun, Jean-Jacques Patard, et al.
Brain Stimulation|November 1, 2011
Clinical research with transcranial direct current stimulation (tDCS): challenges and future directionsAndre Russowsky Brunoni, Michael A Nitsche, Nadia Bolognini, et al.
Frontiers in Immunology|February 4, 2025
Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccineSylvain Lamure, Houria Hendel Chavez, Marie-Ghislaine de Goër de Herve, et al.
Journal of Medicinal Chemistry|July 26, 2019
Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of OsteoporosisAhmed S Abdelsamie, Mohamed Salah, Lorenz Siebenbürger, et al.
Digestive Diseases and Sciences|July 2, 2020
Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective StudyYasmina Ben Merabet, Coralie Barbe, Alexandra Heurgue-Berlot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2014
MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression arrayLaurence Albiges, Justine Guegan, Audrey Le Formal, et al.
Pageof 36